Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
D000818:Animals; D001085:Arabinofuranosylcytosine Triphosphate / Q000378:metabolism; D003561:Cytarabine / Q000008:administration & dosage / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003841:Deoxycytidine / Q000378:metabolism; D003854:Deoxyribonucleotides / Q000378:metabolism; D007939:Leukemia L1210 / Q000188:drug therapy / Q000378:metabolism*; D051379:Mice; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013936:Thymidine / Q000008:administration & dosage*; D013997:Time Factors
D004273:DNA, Neoplasm; D003854:Deoxyribonucleotides; D012334:RNA, Neoplasm; D003561:Cytarabine; D003841:Deoxycytidine; D001085:Arabinofuranosylcytosine Triphosphate; D013936:Thymidine